Everence Capital Management Inc. Acquires New Position in Avantor, Inc. (NYSE:AVTR)

Everence Capital Management Inc. bought a new position in shares of Avantor, Inc. (NYSE:AVTR) during the fourth quarter, HoldingsChannel.com reports. The firm bought 26,350 shares of the company’s stock, valued at approximately $555,000.

Several other large investors have also added to or reduced their stakes in AVTR. Principal Financial Group Inc. increased its stake in shares of Avantor by 146.5% in the third quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company’s stock worth $67,996,000 after purchasing an additional 1,562,018 shares in the last quarter. Retirement Systems of Alabama bought a new position in Avantor in the 3rd quarter worth $21,365,000. Oddo BHF Asset Management Sas purchased a new stake in Avantor in the 3rd quarter worth $2,586,000. Teachers Retirement System of The State of Kentucky raised its holdings in Avantor by 45.8% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 723,178 shares of the company’s stock valued at $18,708,000 after acquiring an additional 227,200 shares during the period. Finally, Toronto Dominion Bank lifted its position in shares of Avantor by 29.3% in the third quarter. Toronto Dominion Bank now owns 83,064 shares of the company’s stock valued at $2,149,000 after acquiring an additional 18,800 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Analyst Upgrades and Downgrades

AVTR has been the subject of several research analyst reports. UBS Group cut their target price on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, October 8th. Robert W. Baird cut their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 target price on shares of Avantor in a report on Thursday, September 26th. Barclays cut their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. Finally, Wells Fargo & Company decreased their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $27.69.

Avantor Price Performance

NYSE:AVTR opened at $21.76 on Friday. The firm has a market capitalization of $14.81 billion, a price-to-earnings ratio of 47.30, a PEG ratio of 2.75 and a beta of 1.28. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The business has a 50 day simple moving average of $21.57 and a 200-day simple moving average of $23.33. Avantor, Inc. has a 1 year low of $19.59 and a 1 year high of $28.00.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.